---

---

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

---

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2005

---

SELECT MEDICAL CORPORATION

---

---

4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055

(717) 972-1100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

---

 

Item 8.01	Other Events

On January 20, 2005, Select Medical Corporation (the “Company”) issued a press release announcing its commencement of a cash tender offer relating to its outstanding $175 million principal amount of 9-1/2% Senior Subordinated Notes due 2009 (the “9-1/2% Notes”) and its outstanding $175 million principal amount of 7-1/2% Senior Subordinated Notes due 2013 (the “7-1/2% Notes”). In connection with the tender offers, the Company is also soliciting consents to effect certain proposed amendments to the indentures governing the 9-1/2% Notes and the
7-1/2% Notes. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01	Financial Statements and Exhibits

(c)		Exhibits.

 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

EXHIBIT INDEX